Video

Dr Robert A. Gabbay Calls for a Shift in Diabetes Care Models

CMS' shift to value-based payments has also shifted diabetes care models from cost-centered systems to cost-savings centers, according to Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center.

CMS’ shift to value-based payments has also shifted diabetes care models from cost-centered systems to cost-savings centers, according to Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center and editor-in-chief of Evidence-Based Diabetes Management.

He added that traditionally, many health systems look to recoup lost investments through procedure revenues; however, physicians ideally want to prevent these future complications and surgeries. Dr Gabbay suggested that the cost-savings system is a way to achieve this goal.

“If you’re going to control overall costs of diabetes, you’ve got to decrease long-term complications and therefore invest in the things that we already know that work,” he said.

Related Videos
Mei Wei, MD.
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Sandra Cueller, PharmD
Ticiana Leal, MD
James Chambers, PhD
Mabel Mardones, MD.
Dr Bonnie Qin
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo